rational design envelope identifies broadly neutralizing human monoclonal antibodies hiv- 
cross-reactive neutralizing antibodies nabs found sera many hiv--infected individuals virologic basis neutralization remains poorly understood used knowledge hiv- envelope structure develop antigenically resurfaced glycoproteins specific structurally conserved site initial cd4 receptor binding probes used identify sera nabs cd4-binding site cd4bs isolate individual b cells hiv--infected donor expressing immunoglobulin genes individual cells identified three monoclonal antibodies including pair somatic variants neutralized % circulating hiv- isolates exceptionally broad hiv- neutralization can achieved individual antibodies targeted functionally conserved cd4bs glycoprotein important insight future hiv- vaccine design 
